Regenxbio (RGNX) Presents Additional Positive Interim Data from Phase I/II Trial of RGX-111 for Treatment of Severe MPS I streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.